King’s College Hospital

Our center is based at King’s College Hospital in London. The clinic receives referrals from all over the world, and acts as a tertiary referral centre for patients from the South East. In a typical year we will see about 200 new patients and fill 400 follow-up slots making this one of the busiest MND clinics in the world.

Contact
Location
King's College Hospital, Denmark Hill, London, UK

Specialists

Ammar Al-Chalabi

Professor of Neurology and Complex Disease Genetics

Professor Ammar Al-Chalabi is head of the Basic and Clinical Neuroscience Department at […]

Ammar Al-Chalabi
Current trials
Recruiting
Phase iii

ALXN1210-ALS-308 trial

Industry trial
This phase 3 trial aims to study the safety and efficacy of the drug ‘ravulizumab’ in people living with ALS. To register for this study, you should contact your local ALS centre or treating physician.
Read more
Recruiting
Phase iii

VALOR study

Industry trial
Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS) with a SOD1 gene mutation.
Read more
In preparation
Phase iii

The Lighthouse 2 trial

Investigator initiated trial
The Lighthouse 2 study is a phase 3 clinical trial in which we will investigate the efficacy of the drug Triumeq.
Read more
In preparation
Phase iii

MAGNET

Platform trial
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more